Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Monitoring for adverse effects in clinical treatments is crucial.

Ritlecitinib is safe and may effectively treat alopecia areata.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Finasteride at 1 mg daily doesn't help hair loss in postmenopausal women and has similar side effects to a placebo.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Elagolix did not effectively treat polycystic ovary syndrome.

RXRα is crucial for proper immune response and links diet to immune function.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Oral minoxidil may help with female hair loss.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

5-ARI therapy may help prevent prostate cancer progression.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Retinoic acid affects male and female muscle energy use and function differently.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.